889939-56-4 Usage
Uses
Used in Organic Synthesis:
6-BOC-4,5,6,7-TETRAHYDRO-THIENO[2,3-C]PYRIDINE-3-CARBOXYLIC ACID is used as a building block for the synthesis of various pharmaceutical compounds and agrochemicals, due to its unique structure and reactivity.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 6-BOC-4,5,6,7-TETRAHYDRO-THIENO[2,3-C]PYRIDINE-3-CARBOXYLIC ACID is used as a key intermediate in the development of bioactive molecules, contributing to the creation of novel drugs and other biologically active compounds.
Used as a Protecting Group for Amino Acids:
6-BOC-4,5,6,7-TETRAHYDRO-THIENO[2,3-C]PYRIDINE-3-CARBOXYLIC ACID also serves as a protecting group for amino acids in chemical reactions, ensuring the selective modification of specific functional groups without affecting the amino acid's reactivity.
Used in Pharmaceutical Industry:
6-BOC-4,5,6,7-TETRAHYDRO-THIENO[2,3-C]PYRIDINE-3-CARBOXYLIC ACID is used as a precursor in the pharmaceutical industry for the synthesis of therapeutic agents, leveraging its unique core structure to enhance drug efficacy and target specific biological pathways.
Used in Agrochemical Industry:
In the agrochemical industry, 6-BOC-4,5,6,7-TETRAHYDRO-THIENO[2,3-C]PYRIDINE-3-CARBOXYLIC ACID is utilized as a starting material for the development of agrochemicals, such as pesticides and herbicides, to improve crop protection and yield.
Check Digit Verification of cas no
The CAS Registry Mumber 889939-56-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,9,9,3 and 9 respectively; the second part has 2 digits, 5 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 889939-56:
(8*8)+(7*8)+(6*9)+(5*9)+(4*3)+(3*9)+(2*5)+(1*6)=274
274 % 10 = 4
So 889939-56-4 is a valid CAS Registry Number.
InChI:InChI=1/C13H17NO4S/c1-13(2,3)18-12(17)14-5-4-8-9(11(15)16)7-19-10(8)6-14/h7H,4-6H2,1-3H3,(H,15,16)
889939-56-4Relevant academic research and scientific papers
PYRIDINESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF
-
Paragraph 00288; 00573-00574; 00579-00580; 00605-00606, (2021/09/26)
The present disclosure provides compounds of Formula (I): and pharmaceutically acceptable salts, solvates, hydrates, polymorphs, co-crystals, tautomers, stereoisomers, isotopically labeled compounds, and prodrugs thereof. The provided compounds may be tumor necrosis factor ("TNF") receptor associated protein 1 ("TRAP1") modulators (e.g., TRAP1 activators). The provided compounds may also rescue the activity in PTEN-induced kinase 1 ("PINK1") loss of function contexts. The provided compounds may also improve mitochondrial health, function, quality, quantity, and/or activity, and/or reduce the production of reactive oxygen species. The provided compounds may also refold or solubilize aggregated or misfolded proteins such as a-synuclein. The present disclosure also provides pharmaceutical compositions comprising the provided compounds; kits comprising the provided compounds or pharmaceutical compositions; and methods of using the provided compounds and pharmaceutical compositions (e.g., for treating a disease in a subject in need thereof).
